Mereo Biopharma Group Plc

Filed a patent for "methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency" on Thu, June 22, 2023

Filed a patent for "methods involving neutrophil elastase inhibitor alvelestat for treating coronavirus infection" on Thu, July 13, 2023

Filed a patent for "vegf/dll4 binding agents and uses thereof" on Thu, September 7, 2023

Filed a patent for "use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta" on Thu, November 16, 2023

Filed a patent for "methods of using anti-sclerostin antibodies in treatment of osteogenesis imperfecta" on Thu, September 8, 2022